Response of Postoperative and Chronic Uveitic Cystoid Macular Edema to a Dexamethasone-Based Intravitreal Implant (Ozurdex)

Journal of Ocular Pharmacology and Therapeutics

Volumn 32, Issue 7, 2016, Pages 442-450

  Garweg, Justus G ^a,b   Baglivo, Edoardo ^c   Freiberg, Florentina J ^d   Pfau, Maximilian ^d   Pfister, Isabel B ^a   Michels, Stephan ^d,e   Zandi, Souska ^a  

^a Lindenhofspital   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Clinique de l'Oeil   (Switzerland)

^d TRIEMLI HOSPITAL   (Switzerland)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DRUG IMPLANT;

ADULT; AGED; ARTICLE; BEST CORRECTED VISUAL ACUITY; CENTRAL RETINAL THICKNESS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EPIRETINAL GLIOSIS; FOLLOW UP; GLIOSIS; HUMAN; INTRAOCULAR PRESSURE; INTRAVITREAL IMPLANT; KAPLAN MEIER METHOD; PHACOEMULSIFICATION; POSTOPERATIVE PERIOD; REIMPLANTATION; RETINA MACULA CYSTOID EDEMA; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS; TREATMENT RESPONSE; UVEITIC CYSTOID MACULAR EDEMA; UVEITIS; VITRECTOMY; ADMINISTRATION AND DOSAGE; CLINICAL TRIAL; COHORT ANALYSIS; DRUG EFFECTS; DRUG IMPLANT; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; MIDDLE AGED; MULTICENTER STUDY; THERAPEUTIC USE;

AGED; CHRONIC DISEASE; COHORT STUDIES; DEXAMETHASONE; DRUG IMPLANTS; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; KAPLAN-MEIER ESTIMATE; MACULAR EDEMA; MIDDLE AGED; RETROSPECTIVE STUDIES; UVEITIS;

EID: 84984879108     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2016.0035     Document Type: Article

References (27)

1. Loewenstein, A., and Zur, D. Postsurgical cystoid macular edema. Dev. Ophthalmol. 47:148-159, 2010.
2. Chu, C.J., Johnston, R.L., Buscombe, C., Sallam, A.B., Mohamed, Q., and Yang, Y.C., United Kingdom Pseudophakic Macular Edema Study Group. Risk factors and incidence of macular edema after cataract surgery: a database study of 81984 eyes. Ophthalmology. pii: S0161-6420(15)01146-X, 2015.
3. Frisina, R., Pinackatt, S.J., Sartore, M., et al. Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane. Graefes Arch. Clin. Exp. Ophthalmol. 253:47-56, 2015.
4. Naik, R.K., Rentz, A.M., Foster, C.S., et al. Normative comparison of patient-reported outcomes in patients with noninfectious uveitis. JAMA Ophthalmol. 131:219-225, 2013.
5. de Smet, M.D. Corticosteroid intravitreal implants. Dev. Ophthalmol. 51:122-133, 2012.
6. Sallam, A., Taylor, S.R., and Lightman, S. Review and update of intraocular therapy in noninfectious uveitis. Curr. Opin. Ophthalmol. 22:517-522, 2011.
7. Hunter, R.S., and Lobo, A.M. Dexamethasone intravitreal implant for the treatment of noninfectious uveitis. Clin. Ophthalmol. 5:1613-1621, 2011.
8. Kapoor,K.G., Wagner, M.G., and Wagner, A.L. The sustainedrelease dexamethasone implant: expanding indications in vitreoretinal disease. Semin. Ophthalmol. 2015:21:1-7.
9. Lowder, C., Belfort, R., Jr, Lightman, S., et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Ozurdex HURON Study Group. Arch. Ophthalmol. 129:545-553, 2011.
10. Tomkins-Netzer, O., Taylor, S.R., Bar, A., et al. Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis. Ophthalmology. 121:1649-1654, 2014.
11. Jabs, D.A., Nussenblatt, R.B., and Rosenbaum, J.T. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am. J. Ophthalmol. 140:509-516, 2005.
12. London, N.J., Chiang, A., and Haller, J.A. The dexamethasone drug delivery system: indications and evidence. Adv. Ther. 28:351-366, 2011.
13. Arcinue, C.A., Cerón, O.M., and Foster, C.S. A Comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis. J. Ocul. Pharmacol. Ther. 29:501-507, 2013.
14. Glybina, I.V., Kennedy, A., Ashton, P., Abrams, G.W., and Iezzi, R. Photoreceptor neuroprotection in RCS rats via lowdose intravitreal sustained-delivery of fluocinolone acetonide. Invest. Ophthalmol. Vis. Sci. 50:4847-4857, 2009.
15. Valamanesh, F., Berdugo, M., Sennlaub, F., Savoldelli, M., Goumeaux, C., Houssier, M., Jeanny, J.C., Torriglia, A., and Behar-Cohen, F. Effects of triamcinolone acetonide on vessels of the posterior segment of the eye. Mol. Vis. 15:2634-2648, 2009.
16. Kiddee, W., Trope, G.E., Sheng, L., et al. Intraocular pressure monitoring post intravitreal steroids: a systematic review. Surv. Ophthalmol. 58:291-310, 2013.
17. Zarranz-Ventura, J., Carreno, E., Johnston, R.L., et al. Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency. Am. J. Ophthalmol. 158:1136-1145.e5, 2014.
18. Bellocq, D., Korobelnik, J.F., Burillon, C., et al. Implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study. Br. J. Ophthalmol. 99: 979-983, 2015.
19. Mayer, W.J., Kurz, S., Wolf, A., et al. Dexamethasone implant as an effective treatment option for macular edema due to Irvine-Gass syndrome. J. Cataract. Refract. Surg. 41: 1954-1961, 2015.
20. Williams, G.A., Haller, J.A., Kuppermann, B.D., et al. Dexamethasone Phase II Study Group. Dexamethasone posteriorsegment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am. J. Ophthalmol. 147:1048-1054, 1054.e1-e2, 2009.
21. Miserocchi, E., Modorati, G., Pastore, M.R., and Bandello, F. Dexamethasone intravitreal implant: an effective adjunctive treatment for recalcitrant noninfectious uveitis. Ophthalmologica. 228:229-233, 2012.
22. Myung, J.S., Aaker, G.D., and Kiss, S. Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant. Clin Ophthalmol. 4:1423-1426, 2010.
23. Sorkin, N., Loewenstein, A., Habot-Wilner, Z., and Goldstein, M. Intravitreal dexamethasone implant in patients with persistent macular edema of variable etiologies. Ophthalmologica. 232:83-91, 2014.
24. Cao, J.H., Mulvahill, M., Zhang, L., Joondeph, B.C., and Dacey, M.S. Dexamethasone intravitreal implant in the treatment of persistent uveitic macular edema in the absence of active inflammation. Ophthalmology. 121:1871-1876, 2014.
25. Adán, A., Pelegrín, L., Rey, A., et al. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients. Retina. 33:1435-1440, 2013.
26. Kim, S.J., Martin, D.F., Hubbard, G.B., et al. Incidence of postvitrectomy macular edema using optical coherence tomography. Ophthalmology. 116:1531-1537, 2009.
27. Yoshimura, T., Sonoda, K.H., Sugahara, M., et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinale diseases. PLoS One. 4:e8158, 2009.